Abnormal HAT activity has been implicated in various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases. For instance, mutations or dysregulation of the p300/CBP family members are often associated with oncogenesis. Similarly, altered acetylation patterns have been observed in Alzheimer's disease and Huntington's disease, highlighting the importance of HATs in maintaining cellular homeostasis.
